Ascendis Pharma Cash from Financing (TTM) Analysis

Ascendis Pharma A/S (ASND)

133.46 +0.33 (+0.25%) USD | NASDAQ | May 10, 16:00

133.62 +0.16 (+0.12%) Pre-Market: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	166.15M
December 31, 2023	145.39M
September 30, 2023	172.90M
June 30, 2023	-6.124M
March 31, 2023	-28.62M
December 31, 2022	418.44M
September 30, 2022	375.47M
June 30, 2022	835.33M
March 31, 2022	862.04M
December 31, 2021	415.75M
September 30, 2021	434.19M
June 30, 2021	681.50M
March 31, 2021	689.50M
December 31, 2020	688.24M
September 30, 2020	701.16M
June 30, 2020	13.70M
March 31, 2020	7.156M
December 31, 2019	552.58M
September 30, 2019	548.84M

Date	Value
June 30, 2019	548.22M
March 31, 2019	542.31M
December 31, 2018	240.02M
September 30, 2018	249.21M
June 30, 2018	379.67M
March 31, 2018	382.46M
December 31, 2017	141.25M
September 30, 2017	256.60M
June 30, 2017	130.13M
March 31, 2017	130.69M
December 31, 2016	130.00M
September 30, 2016	0.5416M
June 30, 2016	4.581M
March 31, 2016	2.909M
December 31, 2015	117.34M
September 30, 2015	181.76M
June 30, 2015	177.05M
March 31, 2015	178.14M
December 31, 2014	63.71M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-28.62M

Minimum

Mar 2023

862.04M

Maximum

Mar 2022

411.09M

Average

426.31M

Median

Cash from Financing (TTM) Benchmarks